By G HossainPosted on August 26, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The FDA granted the approval of Revolution Medicines’ daraxonrasib, now to be known as Rasonque, in pancreatic adenocarcinoma 6.5 months ahead of deadline. RevMed receives early FDA approval for ‘groundbreaking’ pancreatic cancer drug Post navigation BMS ends Cellares pact over cell therapy production problems, triggering layoffsVitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns